Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Allison

Showing results (491-500 of 647) with videos related to

Pageof 65
Sort By:
Gene Therapy|February 28, 2014
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancerJ C Morris, C A Ramlogan-Steel, P Yu, et al.
Cancer Research|May 16, 2000
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockadeA A Hurwitz, B A Foster, E D Kwon, et al.
Science Translational Medicine|March 7, 2014
Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapyDmitriy Zamarin, Rikke B Holmgaard, Sumit K Subudhi, et al.
Immunity|July 16, 2011
T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokineMoses K Donkor, Abira Sarkar, Peter A Savage, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 2, 2001
Body water compartment measurements: a comparison of bioelectrical impedance analysis with tritium and sodium bromide dilution techniquesJ A Simpson, D N Lobo, J A Anderson, et al.
Cancer Immunology Research|July 1, 2015
Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate CancerKatharina Kreymborg, Stefan Haak, Rajmohan Murali, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activationT J Sullivan, J J Letterio, A van Elsas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in miceMeili Zhang, Wei Ju, Zhengsheng Yao, et al.
Nature Communications|August 9, 2016
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapyLewis Zhichang Shi, Tihui Fu, Baoxiang Guan, et al.
Cancer Immunology Research|January 8, 2014
Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patientsShigehisa Kitano, Takemasa Tsuji, Caillian Liu, et al.
Pageof 65

Showing results (491-500 of 647) with videos related to

Sort By:
Pageof 65
Gene Therapy|February 28, 2014
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancerJ C Morris, C A Ramlogan-Steel, P Yu, et al.
Cancer Research|May 16, 2000
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockadeA A Hurwitz, B A Foster, E D Kwon, et al.
Science Translational Medicine|March 7, 2014
Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapyDmitriy Zamarin, Rikke B Holmgaard, Sumit K Subudhi, et al.
Immunity|July 16, 2011
T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokineMoses K Donkor, Abira Sarkar, Peter A Savage, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 2, 2001
Body water compartment measurements: a comparison of bioelectrical impedance analysis with tritium and sodium bromide dilution techniquesJ A Simpson, D N Lobo, J A Anderson, et al.
Cancer Immunology Research|July 1, 2015
Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate CancerKatharina Kreymborg, Stefan Haak, Rajmohan Murali, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activationT J Sullivan, J J Letterio, A van Elsas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in miceMeili Zhang, Wei Ju, Zhengsheng Yao, et al.
Nature Communications|August 9, 2016
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapyLewis Zhichang Shi, Tihui Fu, Baoxiang Guan, et al.
Cancer Immunology Research|January 8, 2014
Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patientsShigehisa Kitano, Takemasa Tsuji, Caillian Liu, et al.
Pageof 65